Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche, Teva and AstraZeneca are all said to be in the mix to buy Celltrion
Fierce Pharma
Wednesday, January 8, 2014 - 11:11am
tags:
Roche, Teva, AstraZeneca, biosimilars, M&A, Celltrion, South Korea
This Overvalued Biotech is in Danger of Plummeting as Much as 30%
Yahoo/Street Authority
Wednesday, January 8, 2014 - 10:18am
tags:
Celgene
Catalyst Pharma says autoimmune disorder drug safe for heart
Reuters
Wednesday, January 8, 2014 - 10:01am
tags:
Catalyst Pharmaceutical Partners, Lambert-Eaton myasthenic syndrome, Firdapse
Is FDA Seeking NSA Capabilities?
Pharma Marketing Blog
Wednesday, January 8, 2014 - 10:00am
tags:
FDA, social media
EarlySense Receives FDA Clearance for New Bedside Monitor
Yahoo
Wednesday, January 8, 2014 - 9:53am
tags:
devices, FDA, Patient Monitoring System, EarlySense
Former CBO director calls for an end to the medtech tax
Mass Device
Wednesday, January 8, 2014 - 9:48am
tags:
device tax, Congressional Budget Office
Medtronic spends $160M on Tyrx and its antibacterial envelopes
Fierce Medical Devices
Wednesday, January 8, 2014 - 9:43am
tags:
Medtronic, devices, Tyrx, antibacterial envelopes, M&A
J&J Innovation launches a discovery pact with fledgling upstart Scholar Rock
Fierce Biotech
Wednesday, January 8, 2014 - 9:39am
tags:
Scholar Rock, JNJ Innovation, JNJ, autoimmune disease
Living Cell Technologies - Breakthrough Opportunity In Diabetes And Parkinson's Drugs
Seeking Alpha
Wednesday, January 8, 2014 - 9:29am
tags:
diabetes, Parkinson's Disease, Living Cell Technologies
NPS Pharmaceuticals sees FY13 net global Gattex sales approx. $31.5M
Yahoo/Fly on the Wall
Wednesday, January 8, 2014 - 9:27am
tags:
Gattex, NPS Pharmaceuticals, revestive
Drugmaker Teva needs strategy reset with new CEO
Yahoo/Reuters
Wednesday, January 8, 2014 - 8:44am
tags:
Teva, Erez Vigodman, Pharma CEOs
Drugmakers' future success "will depend on new R&D paradigms"
Pharma Times, UK
Wednesday, January 8, 2014 - 8:41am
tags:
R&D
Alkermes announces advances with its late-stage CNS pipeline
Yahoo/Fly on the Wall
Wednesday, January 8, 2014 - 8:37am
tags:
Alkermes, aripiprazole lauroxil, schizophrenia, ALKS 5461, major depressive disorder
NuPathe gets takeover offer from Israel's Teva
Reuters
Wednesday, January 8, 2014 - 8:12am
tags:
NuPathe, Teva, M&A
Neostem Could Rally On Phase II Results
Seeking Alpha
Wednesday, January 8, 2014 - 8:11am
tags:
NeoStem, Segment Elevation Myocardial Infarction, AMR-001
AstraZeneca raises bet on cancer immunotherapy with Immunocore deal
Yahoo/Reuters
Wednesday, January 8, 2014 - 8:09am
tags:
Immunocore, AstraZeneca, MedImmune
Nestle enters biotech deal with Cellular Dynamics
Yahoo/Reuters
Wednesday, January 8, 2014 - 8:08am
tags:
Nestle, Cellular Dynamics
Enanta Joins Big Leagues With Hepatitis C Drug
Investors.com
Wednesday, January 8, 2014 - 8:07am
tags:
Enanta, hepatitis C, AbbVie, ABT-450, protease inhibitors
Valeant Dreams Big; Cancer Drug News Lifts Pharmacyclics
Yahoo/Investors Business Daily
Wednesday, January 8, 2014 - 8:05am
tags:
Valeant Pharmaceuticals, Pharmacyclics, Imbruvica, Celgene, EPZ-5676, Epizyme
Forest Labs to buy private peer Aptalis for $2.9 bln
Yahoo/Reuters
Wednesday, January 8, 2014 - 8:03am
tags:
Forest Labs, Aptalis, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.